Detalles de la búsqueda
1.
Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
Surgery
; 161(2): 373-384, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27838102
2.
Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.
Sci Rep
; 6: 19222, 2016 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26753987
3.
Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.
Oncotarget
; 7(5): 5943-56, 2016 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26745601
4.
Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.
Sci Rep
; 6: 25115, 2016 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27174632
Resultados
1 -
4
de 4
1
Próxima >
>>